These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 29679339)
21. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis. Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563 [TBL] [Abstract][Full Text] [Related]
22. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma. Wang G; Li H; Hou Y Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044 [TBL] [Abstract][Full Text] [Related]
23. LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2. Fang G; Wang J; Sun X; Xu R; Zhao X; Shao L; Sun C; Wang Y Ann Hepatol; 2020; 19(5):535-540. PubMed ID: 32546442 [TBL] [Abstract][Full Text] [Related]
24. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway. Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978 [TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis. Shen D; Xu J; Cao X; Cao X; Tan H; Deng H Cancer Biomark; 2021; 30(2):155-165. PubMed ID: 33104021 [TBL] [Abstract][Full Text] [Related]
26. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis. Gong J; Ma L; Peng C; Liu J Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer. Zhang X; Jiang Y; Xie Y; Leng X; Song F DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786 [TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis. Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B Crit Rev Eukaryot Gene Expr; 2023; 33(7):43-56. PubMed ID: 37602452 [TBL] [Abstract][Full Text] [Related]
29. LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7 Cheng W; Shi X; Lin M; Yao Q; Ma J; Li J Front Cell Dev Biol; 2020; 8():552822. PubMed ID: 33330444 [TBL] [Abstract][Full Text] [Related]
30. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia. Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters. Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283 [TBL] [Abstract][Full Text] [Related]
32. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a. Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MAGI2 Wei X; Hou Y; Zhang Y; Zhang H; Sun Z; Meng X; Wang Z J Cancer; 2022; 13(1):343-353. PubMed ID: 34976194 [TBL] [Abstract][Full Text] [Related]
34. lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter. Pu J; Wang J; Wei H; Lu T; Wu X; Wu Y; Shao Z; Luo C; Lu Y Mol Ther Nucleic Acids; 2019 Dec; 18():351-362. PubMed ID: 31629962 [TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA MAGI2-AS3 regulates the H Zhang Y; Qiao X; Liu L; Han W; Liu Q; Wang Y; Xie T; Tang Y; Wang T; Meng J; Ye A; He S; Chen R; Chen C Redox Biol; 2022 Aug; 54():102383. PubMed ID: 35797800 [TBL] [Abstract][Full Text] [Related]
36. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis. Chang H; Zhang X; Li B; Meng X Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706 [TBL] [Abstract][Full Text] [Related]
37. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b. Chai Y; Wang L; Qu Y; Hu Z J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958 [TBL] [Abstract][Full Text] [Related]
38. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p. Zhang J; Wang R Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663 [TBL] [Abstract][Full Text] [Related]
39. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952 [TBL] [Abstract][Full Text] [Related]
40. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer. Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]